Literature DB >> 8222202

Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA).

G Cataldo1, M Braga, N Pirotta, M Lavezzari, F Rovelli, E Marubini.   

Abstract

BACKGROUND: To evaluate the possible influence of a series of clinical angiographic and surgical variables on the 1-year patency of saphenous vein (SV) coronary graft, data collected prospectively in a multicenter randomized clinical trial were analyzed. METHODS AND
RESULTS: The study group included 349 patients--847 SV distal anastomoses--who underwent angiography at a median time of 374 days after surgery. By logistic binomial regression analysis, age, sex, smoking habits, hypertension, high cholesterol, previous myocardial infarction, and angina were not found to be significant factors leading to graft occlusion. Among the angiographic and surgical variables, the following were retained as predictive of higher occlusion risk: (1) vessel diameter (< or = 1.5 mm versus > 1.5 mm, odds ratio (OR) = 2.46); (2) the location of the grafted vessel, namely, the right coronary artery versus the left anterior descending (OR = 2.15); and (3) the wall motion of the vessel-dependent myocardial region (altered versus normal: OR = 2.12). The presence of two or three risk factors multiplied the occlusion risk up to 11-fold.
CONCLUSIONS: The study suggests that vessel diameter, wall motion of the vessel-dependent myocardial region, and location of the grafted vessel are the main determinants of SV coronary graft patency during the first postoperative year. Knowledge of these artery-specific factors may provide a basis for estimating the risk of graft occlusion, thereby modifying surgical strategy and postoperative surveillance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8222202

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

Review 1.  Will drug-eluting stents replace coronary artery bypass surgery?

Authors:  Ross M Reul
Journal:  Tex Heart Inst J       Date:  2005

2.  Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV.

Authors:  Connie N Hess; Renato D Lopes; C Michael Gibson; Rebecca Hager; Daniel M Wojdyla; Brian R Englum; Michael J Mack; Robert M Califf; Nicholas T Kouchoukos; Eric D Peterson; John H Alexander
Journal:  Circulation       Date:  2014-09-26       Impact factor: 29.690

3.  Relative importance of patient, procedural and anatomic risk factors for early vein graft thrombosis after coronary artery bypass graft surgery.

Authors:  R C McLean; S M Nazarian; T J Gluckman; S P Schulman; D R Thiemann; E P Shapiro; J V Conte; J B Thompson; I Shafique; K W McNicholas; T C Villines; K M Laws; J J Rade
Journal:  J Cardiovasc Surg (Torino)       Date:  2011-12       Impact factor: 1.888

4.  Current State of the Art in Approaches to Saphenous Vein Graft Interventions.

Authors:  Michael Lee; Jeremy Kong
Journal:  Interv Cardiol       Date:  2017-09

5.  Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery.

Authors:  Renato D Lopes; Rajendra H Mehta; Gail E Hafley; Judson B Williams; Michael J Mack; Eric D Peterson; Keith B Allen; Robert A Harrington; C Michael Gibson; Robert M Califf; Nicholas T Kouchoukos; T Bruce Ferguson; John H Alexander
Journal:  Circulation       Date:  2012-01-11       Impact factor: 29.690

Review 6.  Physiological insights of recent clinical diagnostic and therapeutic technologies for cardiovascular diseases.

Authors:  Kenji Shigemi; Soichiro Fuke; Dai Une; Keita Saku; Shuji Shimizu; Toru Kawada; Toshiaki Shishido; Kenji Sunagawa; Masaru Sugimachi
Journal:  J Physiol Sci       Date:  2017-07-05       Impact factor: 2.781

7.  Long-term clinical outcomes after coronary artery bypass grafting with pedicled saphenous vein grafts.

Authors:  Mikael Janiec; Örjan Friberg; Stefan Thelin
Journal:  J Cardiothorac Surg       Date:  2018-11-26       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.